Comparative Price Analysis of Biological Products for Treatment of Rheumatoid Arthritis

Comparative Price Analysis of Biological Products for Treatment of Rheumatoid Arthritis

Biological products for treatment of rheumatoid arthritis usually are cost effective for healthcare systems in Europe, but they are huge financial burden due to the high number of patients and the significant budget impact. The expected saving from introduction on the market of biosimilars are signi...

Full description

Bibliographic Details
Main Authors: Manoela Manova, Alexandra Savova, Maria Vasileva, Silvia Terezova, Maria Kamusheva, Daniela Grekova, Valentina Petkova, Guenka Petrova
Format: Article
Language:English
Published: Frontiers Media S.A. 2018-09-01
Series:Frontiers in Pharmacology
Subjects:
biological products
biosimilars
access
prices
rheumatoid arthritis
Online Access:https://www.frontiersin.org/article/10.3389/fphar.2018.01070/full

Similar Items

Similar Items